Skip to main content
IMTX logo

Immatics N.V.

IMTXNASDAQHealthcareBiotechnology

$7.26Today:- (-)1Y −25.93%

As of Oct 27, 2026 close

Market cap
$992.30M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$6.65$12.41
Volume (live)
-
Avg. volume (3M)
987.21K

Immatics (IMTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Immatics reported total assets of EUR 562.10M and total liabilities of EUR 78.20M. Shareholders' equity was EUR 483.89M, down 15.8% from EUR 574.84M a year earlier. Total debt stood at EUR 18.39M against EUR 469.14M in cash and short-term investments, a net cash position of EUR 450.75M. That puts debt-to-equity at 0.04, compared with 0.03 a year earlier.

Immatics Balance Sheet Analysis

Values in billions EUR

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Immatics N.V. (IMTX) - Annual data in billions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.350.240.220.150.130.210.100.04
Short-Term Investments0.120.370.210.210.010.020.020.01
Cash & Short-Term Investments0.470.600.430.360.150.230.120.05
Accounts Receivable0.010.010.010.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.00
Other Current Assets0.030.020.020.010.010.000.000.00
Total Current Assets0.500.630.450.380.150.240.120.06
Non-Current Assets
Property, Plant & Equipment (Net)0.050.060.060.030.020.010.010.00
Intangible Assets0.000.000.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.000.000.000.00
Total Non-Current Assets0.060.070.060.030.020.020.010.01
Total Assets0.560.700.510.410.170.250.130.06
Current Liabilities
Accounts Payable0.000.010.010.010.010.000.000.00
Short-Term Debt0.010.000.000.000.000.000.000.00
Accrued Liabilities0.020.010.020.010.010.00--
Deferred Revenue0.020.040.100.060.050.050.060.02
Other Current Liabilities0.020.020.040.030.030.030.000.00
Total Current Liabilities0.040.070.160.110.100.080.070.03
Non-Current Liabilities
Long-Term Debt0.010.010.010.010.010.000.000.00
Deferred Tax Liabilities0.000.010.010.010.000.000.000.00
Other Non-Current Liabilities0.000.000.000.090.050.000.000.00
Total Non-Current Liabilities0.040.050.140.100.060.090.110.04
Total Liabilities0.080.120.290.200.150.170.180.07
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.000.00
Retained Earnings-0.79-0.59-0.60-0.51-0.54-0.44-0.23-0.20
Accumulated Other Comprehensive Income-0.010.000.000.000.00-0.010.000.00
Additional Paid-in Capital1.281.160.820.710.570.540.190.19
Minority Interest0.000.000.000.000.000.000.000.00
Shares Outstanding0.130.120.080.080.06---
Total Stockholders' Equity0.480.570.220.200.020.09-0.04-0.01
Total Liabilities & Equity0.560.700.510.410.170.250.130.06

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Immatics Balance Sheet

How much debt does Immatics have?

Immatics had total debt of EUR 18.39M as of Dec 31, 2025, against EUR 469.14M in cash and short-term investments. Its debt-to-equity ratio was 0.04. Total debt was EUR 16.20M a year earlier.

What are Immatics's total assets?

Immatics reported total assets of EUR 562.10M as of Dec 31, 2025, down 19.3% from EUR 696.15M a year earlier. Total liabilities were EUR 78.20M.

What is Immatics's shareholders' equity?

Immatics's shareholders' equity was EUR 483.89M as of Dec 31, 2025, or about EUR 3.61 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition